PATENT CLAIM ANALYSIS

Application Number: 15964381
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-11
Patent Classification: ["514", "250000"]

Abstract:
A compound of general formula I, wherein X, R 1 -R 4  take various meanings, for use in the treatment of cancer.

Claim (Index 43):
The compound according to  claim 1  of formula ID, or a pharmaceutically acceptable salt or ester thereof: wherein:\n X is \u2014O\u2014; \n R 1  is \u2014OH or \u2014CN; \n R 2  is a \u2014C(\u2550O)R a  group; \n R 3  is hydrogen or a \u2014OR b  group; \n R 4  is selected from hydrogen, \u2014CH 2 OH, \u2014CH 2 O\u2014(C\u2550O)R c , \u2014CH 2 NH 2  and \u2014CH 2 NHProt NH ; \n R a  is selected from hydrogen, substituted or unsubstituted C 1 -C 12  alkyl, substituted or unsubstituted C 2 -C 12  alkenyl, and substituted or unsubstituted C 2 -C 12  alkynyl; \n R b  is selected from substituted or unsubstituted C 1 -C 12  alkyl, substituted or unsubstituted C 2 -C 12  alkenyl and substituted or unsubstituted C 2 -C 12  alkynyl; \n R c  is selected from substituted or unsubstituted C 1 -C 12  alkyl, substituted or unsubstituted C 2 -C 12  alkenyl, and substituted or unsubstituted C 2 -C 12  alkynyl; and \n Prot NH  is a protecting group for amino.

Metadata:
- Claim Count in Document: 150.0
- Percentile: 91.0
- Lexical Diversity: 1.13043
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14901314', '12899410', '15499532', '13397195', '12883883']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.782717784024295
- 35 USC 102 Novelty (BERT): 0.5339369772808952
- Combined Prediction Score: 0.7578397033499551
- Mean Citation Score: 329.556092
- Max Citation Score: 341.7664
- Similarity Product: 246.92266806182857

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test